Fas (also called APO-1 or CD95) and its physiological ligand, FasL, regulate apoptosis of unwanted or dangerous cells, thereby functioning as a defense against autoimmunity and cancer development.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^ The mechanism by which the 'death receptor\' FAS triggers the apoptosis of cells depends on the cell type.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^

In type I cells, Fas-induced activation of caspase-8 leads to activation of effector caspases and subsequently cell death. In type II cells, including Barth syndrome-derived hepatocytes and pancreatic *β*-cells, cell death requires caspase cascade amplification through caspase-8-mediated activation of the proapoptotic Bcl-2 family member Bid-FL (BH3 interacting domain death agonist-full length).^[@bib5],\ [@bib6],\ [@bib7]^ Caspase-8 cleaves Bid-FL, which is a member of the Bcl-2 family, and the resulting truncated Bid (tBid) activates the mitochondria.^[@bib8],\ [@bib9]^ Mitochondria are activated in both type I and type II cells, but this activation is not strictly necessary for the death of type I cells. Upon activation, mitochondria release pro-apoptotic molecules, including cytochrome *c* and Smac/DIABLO.^[@bib10]^ Once in the cytosol, cytochrome *c* induces the activation of the apoptosome leading to the activation of further downstream caspases and the end result is apoptosis.

The importance of specific protein--lipid interactions for the proper functioning of an organelle is clearly exemplified within the inner membrane (IMM) of mitochondria, in which most of the unique phospholipid, cardiolipin (CL), is found.^[@bib11]^ CL is associated with all of the major players in oxidative phosphorylation, including complexes I, III, IV and V, and the major carrier proteins for adenine nucleotides and phosphates.^[@bib12]^ The absence of CL results in structural abnormalities in the organization of complexes that have direct functional consequences. CL has been described to be enriched by 10 to 20% in the contact site between the two mitochondrial membranes.^[@bib13]^ CL is a structurally unusual phospholipid with one negative charge at physiological pH associated with its two headgroups and four associated fatty acyl chains.^[@bib14]^ CL is synthesized by CL synthase, in the matrix-facing leaflets of the IMM.^[@bib9]^ Newly synthesized CL undergoes a remodeling process during which saturated acyl chains are replaced with more unsaturated chains, thereby establishing a high degree of acyl chain symmetry.

CL is associated with several mitochondrial-dependent apoptotic steps,^[@bib15]^ including the proapoptotic function of Bcl-2 family proteins. CL can serve as a docking site for tBid^[@bib16]^ and is subsequently required for Bax activation and the destabilization of mitochondrial membrane structure and function.^[@bib17]^ By anchoring cytochrome *c* to the IMM, CL both facilitates the electron transport chain and hinders cytochrome *c* release during apoptosis, evidence that complete release of cytochrome *c* requires the disruption of its interactions with CL. CL peroxidation and degradation facilitates such disruption.^[@bib18]^

Pro-caspase-8 is mostly in the cytosol, but is also loosely associated with the mitochondrial outer membrane (OMM).^[@bib19],\ [@bib20]^ We recently reported that Fas receptor activation induced the translocation of active caspase-8 to the mitochondrial surface, a step that was dependent on the presence of mature CL in the OMM.^[@bib21]^ This translocation of caspase-8 was necessary for the activation and amplification of caspase-8 processing. Immortalized lymphoblasts from a Barth syndrome patient containing non-mature CL exhibit a blockage of the signal transduction through mitochondria, showing that CL is required for this process.

Our discovery of an activation platform formed by CL/Caspase-8/Bid-FL at mitochondrial contact sites^[@bib21]^ opens various possibilities for research. In particular, more detailed biophysical analysis of the behavior of active caspase-8 and of Bid-FL binding is needed to understand the interactions between the various components of the platform.

Here, we describe the development of an experimental biomimetic system as a model for studying interactions between proteins (active caspase-8 and Bid-FL) and the mitochondrial OMM. It also allows the development of tools for measuring the effects of binding between the components.

Our approach was to identify a minimal physico-chemical system that models mitochondrial contact sites and the interaction of caspase-8/Bid-FL with CL. It involves giant unilamellar vesicles (GUVs) as model membrane system. We first validated flow cytometry for the analysis of GUVs on a routine basis. Then, we show how flow cytometry measurements can be used to measure binding between GUVs and putative components constituting the functional enzymatic platform.

Results
=======

GUV analysis by flow cytometry
------------------------------

Physiological membrane systems, such as mitochondrial membranes and their contact sites, are extremely complex. To develop an experimental model of such systems, we used a cell-free reconstituted system constituted of GUVs with defined phospholipid composition. These are the membrane systems that have the advantages of being freestanding bilayers a few to hundred micrometers in diameter, suitable for flow cytometry analysis ([Figure 1](#fig1){ref-type="fig"}) and confocal microscopy.

We used this experimental model to study the interactions between CL and other highly purified proteins. First, we validated the use of flow cytometry for the study of GUVs. The light-scattering properties of GUVs were used to follow vesicle size changes, and NAO staining was used to measure their CL content ([Figure 1](#fig1){ref-type="fig"}). Beads of defined size were added to GUV samples to facilitate measuring GUV size ([Figure 1a](#fig1){ref-type="fig"}). Most of the GUVs were larger than the 10 *μ*m beads, and in the range 10 to 100 *μ*m in diameter.

The GUVs were homogeneously stained by NAO with the labeling intensity depending on their size ([Figure 1b](#fig1){ref-type="fig"}) and CL content ([Figure 1c](#fig1){ref-type="fig"}). There was a linear relationship between CL content and NAO fluorescence. We examined GUVs of various compositions by confocal imaging. This confirmed the staining of GUVs containing CL by NAO and weak fluorescence of GUVs devoid of CL ([Figure 1 c--e](#fig1){ref-type="fig"}). The vesicles with 90 : 10 PC/CL composition appeared round and mostly devoid of internal structures. They were also easy to handle. We, therefore, used this GUVs composition for all subsequent experiments, except where indicated otherwise.

tBid binds to GUVs containing CL
--------------------------------

tBid induces the destabilization of mitochondrial membranes and changes in their functional activity^[@bib17],\ [@bib22]^ by binding to the CL at contact sites. This binding depends essentially on the interaction between the hairpin-forming domain of tBid and CL both.^[@bib24]^ This also appears to be the case when using CL-containing phospholipid monolayers.^[@bib25]^

We investigated the binding and effects of tBid on GUVs containing or not containing CL. tBid did not bind to vesicles containing only phosphatidylcholine ([Figure 2a, b, e and f](#fig2){ref-type="fig"}), but showed specific binding to GUVs containing CL (([Figure 2c, d, g and h](#fig2){ref-type="fig"}). This is consistent with previous findings concerning CL-mediated selectivity of tBid interactions with lipid membranes.^[@bib16],\ [@bib22],\ [@bib25],\ [@bib26],\ [@bib27],\ [@bib28]^ The weak non-specific binding did not modify the light scatter or the fluorescence of PC-only-GUVs ([Figure 2b and f](#fig2){ref-type="fig"}). We then investigated the consequences of this tBid binding for the light-scattering properties of CL-GUVs ([Figure 2c and g](#fig2){ref-type="fig"}). The addition of 20 nM tBid to CL-GUVs (online addition) was immediately followed by tBid binding and a substantial change in light-scattering properties. The GUVs became smaller and the SSC increased. Indeed, the CL-GUVs broke down and re-vesiculated at smaller sizes (39% under 10 *μ*m) than the initial and control CL-GUVs vesicles (29% under 10 *μ*m). The tBid fluorescence was clearly associated with the low SCC vesicle population ([Figure 2h](#fig2){ref-type="fig"}).

Active caspase-8 preferentially binds CL-containing GUVs
--------------------------------------------------------

The activation of caspases often involves the formation of triggering complexes. Many such complexes, or activation platforms, have been described in the vicinity of the plasma membrane: the death-inducing signaling-complex (DISC) for caspase-8 and -10,^[@bib29]^ the apoptososme for caspase-9,^[@bib30]^ the PIDDosome for caspase-2 and the inflammasome for caspase-1 and -5.^[@bib31]^ The auto-processing of caspase-8 into fully active caspase-8 at the DISC involves two steps. First, upon homodimerization, pro-caspase-8 (p55) is cleaved into two active subunits (p43 and p10). The second cleavage is in p43 between the DED and the p18 subunits to generate the fully active p18/p10 form. The first cleavage product, p43/p10, associates with CL-containing membranes and is resistant to alkaline wash, suggesting that it is inserted into the mitochondrial OMM.^[@bib21]^ Indeed, this was the first proof of caspase-8^[@bib32]^ integration into the mitochondrial membrane.^[@bib16]^ The resistance to alkaline washing suggests that hydrophobic interactions with the unsaturated acyl chain of CL may contribute to the stability of the complex formed by CL and p18/p10. However, such bound caspase-8 is sensitive to trypsin proteolysis indicating that it remains accessible from the cytosol.^[@bib21]^

We investigated the selectivity of the interaction between caspase-8 and GUVs of different lipid compositions ([Figure 3](#fig3){ref-type="fig"}). Vesicles containing and those not containing CL exhibited similar autofluorescence ([Figure 3a and c](#fig3){ref-type="fig"}). As added caspase-8 is not fluorescent, we used an indirect measurement with FITC-VAD-fmk as a reporter of the presence of the active caspase-8 at the GUV surface ([Figure 3](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). The binding of active caspase-8 to CL-GUVs was almost seven times greater than that to PC-only-GUVs (fluorescence of 853 and 136, respectively, [Figure 3b and d](#fig3){ref-type="fig"}). The signal for PC-only-GUVs presumably relflect non-specific binding. The fixation of the fluorescent reporter molecule (FITC-VAD-fmk) to the active site of caspase-8 molecules can be inhibited by z-VAD-fmk, a widely used pan-caspase inhibitor. z-VAD-fmk did not affect autofluorescence or non-specific binding. We tested the effects of this and other caspase inhibitors on FITC-VAD-fmk staining of bound active caspase-8 ([Table 1](#tbl1){ref-type="table"}). Both the general caspase inhibitors (z-VAD-fmk and Boc-D-fmk) and the specific caspase-8 inhibitor (z-IETD-fmk) effectively abolished FITC-VAD-fmk staining of caspase-8 linked to GUVs. Bcl-X~L~ΔCT,^[@bib33]^ which binds vesicles independently of the CL content, did not interfere with this staining ([Table 1](#tbl1){ref-type="table"}).

Formation of a functional enzymatic complex between caspase-8, Bid-FL and CL
----------------------------------------------------------------------------

One hypothesis is that, CL provides an activation platform upon which caspase-8 can cluster, oligomerize and be processed into both p43/p10 and p18/p10. Indeed, the amount of caspase-8 accumulating at the DISC in type II cells is very small and even not detectable by western blotting; this led to the suggestion that a mitochondrial step is necessary for amplification (i.e., caspase-8 accumulation at the mitochondrial membrane level and recruitment of Bid-FL).^[@bib34]^ The p43/p10 on the outer mitochondrial membrane is cross-linked to other p43/p10 molecules to form high-molecular weight oligomers, reinforcing this view.^[@bib21]^ This also suggests that caspase-8 processing to its active form (p18/p10) occurs on the mitochondria and involves a CL-dependent system. Bid-FL (the substrate), which does not bind to CL, may then be brought together with caspase-8 (the active enzyme) at this site in which the interaction produces tBid (the product).

To test this hypothesis, we first targeted active caspase-8 to PC-only- and CL-GUVs and then added Alexa-labeled Bid-FL ([Figure 4](#fig4){ref-type="fig"}). The system was highly non-saturable in the presence of CL and caspase-8. Caspase-8 addition did not modify either the light scatter or the autofluorescence of the GUVs ([Figure 4a and e](#fig4){ref-type="fig"}). The immediate measurements (*t*=0) correspond to the fluorescence of Bid-FL on CL-GUVs ([Figure 4b and f](#fig4){ref-type="fig"}). In less than two minutes, two populations were distinguishable in terms of light scattering and of Bid-FL-Alexa647 (nm) fluorescence ([Figure 4c and g](#fig4){ref-type="fig"}). The fluorescence of vesicles of high FSC and low SSC (25--30% of the GUVs) was similar to that of the stained control population, whereas a new population of low FSC and high SSC (51%) appeared with a higher fluorescence ([Figure 4g](#fig4){ref-type="fig"}). Possibly, the enzymatic system was rapidly active in the presence of the three components (CL/Caspase-8 and Bid-FL), all together in the vicinity of the vesicles, such that tBid was generated and active (similar to the effect of tBid described in [Figure 2d and h](#fig2){ref-type="fig"}). After 45 min, only small GUVs with high SCC were detected in significant abundance (30% of all objects detected). They exhibit weak fluorescence evidence of the cleavage of the fluorescent Bid-FL-Alexa647 (nm) ([Figure 4i](#fig4){ref-type="fig"}) to generate tBid (non-fluorescent). In parallel, there was re-vesiculation of the GUVs at smaller size (low FSC) and with larger side scatter (high SSC) ([Figure 4d](#fig4){ref-type="fig"}) and complete destruction of some (not directly visualized on histograms because the threshold imposed on the FSC, but nevertheless calculable). The sequence of events is schematized in [Figure 5](#fig5){ref-type="fig"}, together with a statistical analysis of the generation of small vesicles (low FSC/high SSC) from the initial population of GUVs (high FSC/low SSC). It is clear that the amount of small vesicles generated is smaller than the number of GUVs initially present (75±7% of the total events). [Figure 5b--d](#fig5){ref-type="fig"} shows the various subpopulations as revealed by confocal analysis of CL-GUVs stained red with a lipid marker (and incubated with caspase-8 and Bid-FL-Bopipy 488 nm); the types of vesicles visualized included normal-sized round-shaped vesicles (over 10 *μ*m FSC high/SSC low) ([Figure 5b](#fig5){ref-type="fig"}), small round vesicles (below 10 *μ*m FSC low/SSC high) ([Figure 5c](#fig5){ref-type="fig"}) and various fluorescent debris that had a tendency to aggregate ([Figure 5d](#fig5){ref-type="fig"}).

Discussion
==========

Given that the amount of active caspase-8 generated at the DISC during type II cell apoptosis is very low, it seems likely that the mitochondrial steps are necessary for the amplification of the apoptotic signals required for extrinsic apoptosis execution.^[@bib34]^ In this work, we tested in a reconstituted system the following hypothesis: active caspase-8 binds to a CL-enriched domain at mitochondrial contact sites in which it constitutes an activation platform,^[@bib21]^ upon which active caspase-8 can recruit Bid-FL and process it to generate tBid.

First, we show that the combination of a new biometric system with a powerful quantitative technique -- flow cytometry -- allows systematic and statistically valid studies of active caspase-8 and Bid-FL interaction with lipid membranes. Using PC-GUVs containing or not containing CL as a model of mitochondrial contact sites, we were able to reproduce features of active caspase-8 binding to the functionalized mitochondrial membranes recently described using Barth syndrome-derived cell lines.^[@bib21]^ Investigations of the binding of active caspase-8 is challenging in cells, but is facilitated in this experimental model. Caspase-8 preferentially binds to CL in GUVs and indeed its non-specific binding to PC-GUVs is weak. This is consistent with the view that active caspase-8 is specifically targeted to mitochondria upon activation. This does not resolve the question of the affinity of the pro-active form of caspase-8 for CL. Nevertheless, such interaction appears to occur, followed by the recruitment of further pro-caspase-8 molecules that homodimerize and undergo the cleavage events necessary for caspase-8 activation. We showed that CL strongly supports the binding of active caspase-8 to the GUVs. In this study, we have tested four concentrations of CL (5, 10, 15 and 20%) and found that 5% of CL was sufficient to provide maximal binding of active caspase-8 to the GUVs (data not shown).

Our investigations are also informative concerning the possibility of constituting a complete platform composed of CL/caspase-8 and Bid-FL. After death receptor engagement, the activation of caspase-8 results in the cleavage of Bid-FL to give a truncated form of tBid.^[@bib35]^ tBid then translocates to mitochondria and induces the oligomerization of Bax/Bak; this leads to cytochrome *c* release and activation of executioner caspase-3 and -9. Immunoelectron microcopy suggests that tBid is targeted in a CL-dependent manner to the contact sites.^[@bib16],\ [@bib25]^ The minimal requirement of tBid binding to CL-enriched contact sites was shown to be *α*-helices 6^[@bib36]^ with a functional activity toward the respiratory chain linked to *α*-helices 6--8.^[@bib23]^ Note that tBid binds to CL and CL derivatives, such as monolysocardiolipin (MLCL). Consequently, even if the CL is not mature, tBid can still bind MLCL that is sufficient for directing tBid translocation to the mitochondria.

We tested the effect of tBid binding to GUVs. We found unambiguously that tBid binds very efficiently and specifically to CL-GUVs at nM concentrations. Moreover, tBid binding and its subsequent effects were very fast and induced GUVs rupture followed by re-vesiculation or even total destruction. This is consistent with our recent results concerning the interaction between CL-containing lipid monolayers and the constitution of lipid microdomains induced by tBid (or by the hairpin-forming domain of tBid).^[@bib23],\ [@bib24]^ As we can follow tBid generation on CL-GUVs, we now have a tool for testing the functional activity of a potential activation platform composed of CL/caspase-8/Bid-FL.

We found that Bid-FL alone was unable to bind to either PC-only-GUVs or CL-GUVs (even those containing 20% CL, result not shown). Although there is some controversy, we confirmed previous findings that Bid-FL does not bind to CL.^[@bib33]^ Bid-FL bound to CL-GUVs only if active caspase-8 was present at the vesicle surface. Active caspase-8 binding to CL is, in practice, non-saturable, this is also the case for Bid-FL. We found that the complexes formed very quickly and rapidly became enzymatically active; the process was too fast to be followed by imaging of GUVs by confocal microscopy. Within 2 min, the CL-GUVs samples exhibited two subpopulations both stained by Bid-FL Alexa647, one similar to the initial or control GUVs and one composed of smaller GUVs with high SSC. After 45 min the initial CL-GUV population and its fluorescence associated with Bid-FL had been lost (because the truncated form is non-fluorescent). A third population of components was also generated by the activity of the platform: fluorescent debris from broken GUVs with high fluorescence and a tendency to aggregate.

Studies with our model vesicles indicate that active capase-8 binds to CL, and Bid-FL subsequently binds to the fixed active caspase-8 at its cleavage site leading to tBid generation. tBid is in turn the driving force destabilizing the vesicles, presumably through increased membrane curvature as described by Epand *et al.*^[@bib26]^ Indeed, our approach, based on flow cytometry with the newly developed biomimetic model of mitochondrial contact sites, strongly supports the hypothesis of the formation of a platform composed of caspase-8 and Bid-FL bound to CL. Our major finding is that Bid-FL requires the presence of caspase-8 for binding to GUVs, and this provides further insight into the nature of the so-called 'mitosome\'-triggering complex.

Materials and Methods
=====================

Protein preparation
-------------------

We prepared fluorescently labeled human tBID as described^[@bib37]^ from BID complementary (cDNA) in pET15b encoding a single cysteine at position 64 in the tBID fragment, and labeled it with Alexa647 maleimide (Invitrogen, Cergy-Pontoise, France).^[@bib33]^ We purified full-length BID by the same protocol as that used for tBID, but from a cDNA with C15S and C28S mutations, and labeled it with Bodipy or Alexa647 maleimide.^[@bib33]^ Bcl-X~L~ΔC was prepared as described^[@bib33]^ by Garcia-Saez *et al.*^[@bib33]^

Preparation of GUVs
-------------------

All lipids were from Avanti Polar Lipids (Alabaster, AL, USA). We prepared GUVs by the electroformation method. We spread 5 *μ*l of lipid mixture at 1 mg/ml in chloroform on two Pt wire electrodes. We immersed the lipid films in a chamber containing 300 mM sucrose solution and connected the Pt wires to a power generator. Electroformation was at 2.3 V and 10 Hz for 1 h at room temperature, and the GUVs formed were released from the electrodes by changing the frequency to 2 Hz for 30 min.^[@bib33]^

Protein binding and image analysis
----------------------------------

Aliquots of 50 *μ*l of the electroformed GUVs were sedimented in 500 *μ*l PBS containing the corresponding proteins. GUV labeling was assessed by confocal microscopy. We added 25 nM of nonyl acridine orange (NAO) to reveal the presence or absence of CL; after 30 min of incubation at room temperature the resulting fluorescence was measured in the green channel. DiD (DiIC~18~(5), 0.05% (mol)), a lipophilic carbocyanine dye, was used to vizualize vesicles, imaged in the red channel, independently of their CL content. We used an LSM 510 Meta microscope (Zeiss, Jena, Germany) with a 40 × 1.2 NA C-Apochromat water objective (Zeiss) in the multi-track mode. UV/488/543/633 and 545 nm filters were used as main and secondary dichroics. The green channel consisted of an Ar laser with excitation wavelength at 488 nm and a 505--530-nm band-pass filter, whereas we configured the red channel with a 633-nm excitation laser and a 650-nm long-pass filter.

Flow cytometry analysis of GUVs
-------------------------------

For flow cytometry analysis, pre-incubation when appropriate was performed with 10 *μ*l of electroformed GUVs in 100 *μ*l of PBS (subsequently made up to 1 ml in PBS for flow cytometry analysis). The pre-incubated GUVs were sedimented and the pellet was washed to eliminate non-specific binding of dyes and proteins. Some current experiments were performed on-line in the flow cytometer, in which case 10 *μ*l of the GUV preparation was diluted to 1 ml in PBS and then passed through the flow cytometer; the reaction was started by addition of proteins directly to the tube during data recording and the enzymatic activity was measured either as changes in light scatter or by fluorescence measurement. Forward low-angle light scatter (FSC) and side scatter (SSC) were recorded. We measured NAO fluorescence in the green channel. We checked that non-specific binding of proteins was limited in parallel experiments involving sedimentation of GUVs in dye- or protein-free media (data not shown).

We used CaspACE FITC-VAD-fmk (Promega, Charbonnieres, France), a fluorescent derivative of VAD-fmk, at 500 nM to stain the active site of caspase-8 (100 nM, non-labeled) bound to GUVs. We performed control experiments with the non-fluorescent caspase-8 inhibitors Z-VAD- fmk (5 *μ*M), Boc-D-fmk (500 nM) and, more specific for caspase-8, Z-IETD-fmk (500 nM). The amount of FL-Bid Alexa647 added is always 100 nM.

We used a FACS Calibur4C (Becton-Dickinson, Franklin Lakes, NJ, USA) equipped with an argon laser at 488 nm and a red diode laser at 635 nm. A 530±30 nm band pass filter was used for green fluorescence (448 nm excitation) and a 661±16 nm band pass for the red fluorescence (excitation 635 nm). Beads of known size (10 *μ*m diameter) were added to the samples as size markers when appropriate. Given the strength of the light-scattering properties of the GUVs used in our study, we recorded the FSC and theSSC, and a particle threshold was set on the FSC to exclude debris and very small particles.

This work was supported by the Association Française contre les Myophaties (grant number 11557 and to PXP). We thank Jean-Claude Martinou (University of Geneva, Switzerland) for providing us with purified active caspase-8.
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![Flow cytometry analysis of GUVs and nonyl acridine orange staining of CL. (**a**) Light-scattering properties (FSC/SSC) of a GUV preparation composed of 90 : 10 PC/CL. Fluorescent beads (10 *μ*m) were included in the sample as size standards. Gates G1 and G2 define two GUV subpopulations, with G1 for GUVs with FSC lower than beads and G2 for GUVs with FSC higher than the beads (the GUVs in this sample are between 10 to 90 *μ*M across). The number of GUV in each subpopulation is given. (**b**) Biparametric histograms of FSC *versus* NAO fluorescence. The histograms of fluorescence (top left) and FSC (bottom right) are given for the G3 and G4 populations. (**c**) Relationship between GUV cardiolipin content and NAO fluorescence. All data reported correspond to analysis of 2500 events. The values for mean fluorescence are given in arbitrary units (a.u.) with S.D. (*n*=10). (**d--f**) Confocal microscopy of GUVs with different CL contents. (**d**) PC only, (**e**) PC/CL 90 : 10 and (**f**) PC/CL 80 : 20](cddis201081f1){#fig1}

![Effets of tBid binding to GUVs containing CL. GUVs constituted of PC only (panels **a, b, e** and **f**) or of PC/CL 90 : 10 (**c, d, g** and **h**) were studied. The GUVs were treated or not treated with 10 nM tBid. (**a--d**) Light-scattering properties of the GUVs (FSC/SCC). The percentage of vesicles in each gated population is shown. (**e--h**) tBid-Bodipy Alexa647 *versus* SSC. The values reported are the mean SSC *versus* the mean Alexa fluorescence of the selected populations (**a--d**)](cddis201081f2){#fig2}

![Flow cytometry analysis of caspase-8 binding to GUVs containing CL. FITC-VAD-fmk (500 nM), a fluorescent marker of the caspase-8 active site, was used to stain caspase-8 bound to the vesicles. (**a**) PC-only-GUV control (autofluorescence at 488 nm excitation). (**b**) Binding of caspase-8 to PC-only-GUVs: red line, in the absence of z-VAD-fmk (non-fluorescent); black line, following pre-incubation with 5 *μ*M z-VAD-fmk. (**c**) CL-GUV (composition 90 : 10 PC/CL) control (autofluorescence). (**d**) Binding of caspase-8 to GUVs containing CL (90 : 10 PC/CL): blue line, in the absence of z-VAD-fmk; black line, after preincubation with 5 *μ*M z-VAD-fmk. Reported values are mean fluorescence and S.D.s for 2500 events involving GUVs over 10 *μ*m in diameter (*n*=11)](cddis201081f3){#fig3}

![Reconstitution of the caspase-8/Bid/CL platform in GUVs. (**a--i**) Kinetics of Bid-FL activity on CL-GUVs in presence of active caspase-8. CL-containing GUVs (90 : 10 PC/CL) pre-treated with 100 nM of active caspase-8 were incubated with Alexa647-labeled Bid-FL. Light-scattering properties (FSC/SSC, panels **a--d**) and Alexa647 fluorescence (panels **e--i**) of the GUVs were measured by flow cytometry at time 0, 2 and 45 min after incubation. Inserts in panel **a** and **e** represent the effect of the addition of active caspase-8 on GUVs. The data are the mean of 12 experiments. (**j**) CL promotes the binding of Bid-FL to the GUVs in presence of caspase-8 (100 nM). PC/CL (100 : 0) and PC/CL (90 : 10) containing GUVs were pretreated with 100 nM of active caspase-8 and incubated with increasing concentration of Alexa647-labeled Bid-FL (12.5, 25, 50 and 100 nM). Alexa647 fluorescence of the GUVs was measured by flow cytometry](cddis201081f4){#fig4}

![CL-GUV distribution after formation of caspase-8/Bid-FL platform and image analysis. (**a**) The two types of GUVs (over 10 *μ*m and under 10 *μ*m) and the fluorescent debris in various conditions and after various times (in minutes). In black, the high FSC GUVs and in white, the low FSC GUVs. (**b--d**) Confocal images after staining with DiD (0.05% (mol)). Caspase-8 (500 nM) and FL-Bid-Alexa647 (100 nM) were added sequentially to the GUV preparations. The debris results from the action of tBid produced by the newly formed enzymatic platform](cddis201081f5){#fig5}

###### Staining of caspase-8 bound to GUVs with CaspACE in the presence or absence of caspase inhibitors

  **CaspACE**    **Caspase-8 inhibitors**           **Mean fluorescence in A.U.**
  -------------- ---------------------------------- -------------------------------
  ---            ---                                7.5±1.9
  FITC-VAD-fmk   ---                                138.9±24.5
  FITC-VAD-fmk   IETD-fmk                           35.9±6.9
  FITC-VAD-fmk   z-VAD-fmk                          43.5±7.9
  FITC-VAD-fmk   Boc-D-fmk                          41.5±8.1
                                                     
                 **Anti-apoptotic family member**    
  FITC-VAD-fmk   Bcl-X~L~ΔCt                        136.8±25.6

The GUVs were preincubated for 15 min with or without caspase inhibitors and then analyzed by flow cytometry. The fluorescent marker FITC-VAD-fmk (500 nM) was added on-line and measurements were made immediately. All caspase inhibitors and the anti-apoptotic family member Bcl-X~L~ΔCt (250 nm) were pre-incubated with the samples for 30 min before addition of FITC-VAD-fmk.
